Old Web
English
Sign In
Acemap
>
authorDetail
>
Sandeep P. Inamdar
Sandeep P. Inamdar
Pathology
Medicine
Cancer research
Oncology
Internal medicine
5
Papers
40
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 1a/1b study of first-in-class B7-H4 antibody, FPA150, as monotherapy in patients with advanced solid tumors.
2019
Journal of Clinical Oncology
Jasgit C. Sachdev
Todd Michael Bauer
Sant P. Chawla
Shubham Pant
Amita Patnaik
Zev A. Wainberg
Sandeep P. Inamdar
Neyssa Marina
Stefanie Sun
Maike Schmidt
Hong Xiang
Patricia LoRusso
Show All
Source
Cite
Save
Citations (5)
Pharmacodynamics (PD) and genomic profiling of pts treated with cabiralizumab (cabira) + nivolumab (NIVO) provide evidence of on-target tumor immune modulations and support future clinical applications.
2018
Journal of Clinical Oncology
Michael Carleton
Janine Powers
Penny Phillips
Muhammad Shaalan Beg
James J. Lee
Osama E. Rahma
Sarina Anne Piha-Paul
Ernestine Lee
Kevin Hestir
Ke Xu
Dimple Pandya
Sandeep P. Inamdar
Serena Perna
Shih-Min A. Huang
Zev A. Wainberg
Show All
Source
Cite
Save
Citations (7)
Updated antitumor activity and safety of FPA144, an ADCC-enhanced, FGFR2b isoform-specific monoclonal antibody, in patients with FGFR2b+ gastric cancer.
2017
Journal of Clinical Oncology
Daniel V.T. Catenacci
Sun Young Rha
Y. Bang
Zev A. Wainberg
Joseph Chao
Keun-Wook Lee
Wolfgang Michael Korn
Yeul Hong Kim
Eun Kee Song
Chang Fang Chiu
Chia-Jui Yen
Jordan Berlin
Jin Soo Kim
Robert Sikorski
Helen Collins
Lee Clark
Sandeep P. Inamdar
Charlie Zhang
Jeeyun Lee
Show All
Source
Cite
Save
Citations (9)
1